Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of sodium valproate and levetiracetam for migraine prevention
IRCT20171030037093N14Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of valproic acid and levetiracetam in migraine (2 arms), sponsored by Shahrekord University of Medical Sciences. Started Jul 2019; status: completed.
02
Drugs
valproic acidlevetiracetam
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20171030037093N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N14.